Stock 002393 TIANJIN LISHENG PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tianjin Lisheng Pharmaceutical Co.,Ltd.

Equities

002393

CNE100000NJ9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
24.76 CNY +1.73% Intraday chart for Tianjin Lisheng Pharmaceutical Co.,Ltd. +0.81% -5.13%
Apr. 24 Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 22 Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4% MT

Business Summary

Tianjin Lisheng Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the manufacture and distribution of chemical drugs. The Company's major products are tablets, hard capsules, pills, free-dry powder injections, water injections and raw drugs, including drugs for cardio and cerebral vascular systems, anti-infection drugs and hormone drugs, among others. It distributes its products mainly within domestic markets.

Number of employees: 1,328

Sales per Business

CNY in Million2022Weight2023Weight Delta
Tablet
70.9 %
769 67.1 % 818 70.9 % +6.31%
Injection
17.4 %
225 19.6 % 201 17.4 % -10.64%
Capsule
7.8 %
98 8.6 % 89 7.8 % -9.18%
Others
3.9 %
10 0.9 % 45 3.9 % +360.84%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,147 100.0 % 1,153 100.0 % +0.56%

Managers

Managers TitleAgeSince
Fu Jun Wang CEO
 Chief Executive Officer 57 17-11-14
Jia Ying Wang DFI
 Director of Finance/CFO 41 -
Zi Long Liu IRC
 Investor Relations Contact - -
Fei Fei Ma IRO
 Public Communications Contact 46 -
Chang Feng Long PRN
 Corporate Officer/Principal 50 19-03-20

Members of the board

Members of the board TitleAgeSince
Ping Zhang CHM
 Chairman 55 22-11-02
Fu Jun Wang CEO
 Chief Executive Officer 57 17-11-14
Mei Zhang BRD
 Director/Board Member 54 20-12-27
Ke Xiang Yu BRD
 Director/Board Member 54 -
Qian Wang BRD
 Director/Board Member 51 17-11-14
Jian Xin Fang BRD
 Director/Board Member 78 20-12-27
Ying Lei BRD
 Director/Board Member 67 21-12-29
Fei Teng BRD
 Director/Board Member 45 23-05-04
Li Jun Sun CHM
 Chairman 41 23-07-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 186,066,992 82,393,794 ( 44.28 %) 1,822,000 ( 0.9792 %) 44.28 %

Shareholders

NameEquities%Valuation
Hwabao WP Fund Management Co., Ltd.
0.2430 %
441,500 0.2430 % 2 M ¥
Gfund Management Co., Ltd.
0.0905 %
164,400 0.0905 % 565 480 ¥
Galaxy Asset Management Co., Ltd.
0.0623 %
113,200 0.0623 % 389 370 ¥
Yimin Asset Management Co., Ltd.
0.0280 %
50,800 0.0280 % 174 735 ¥
Broad Fund Management Co. Ltd.
0.0176 %
32,000 0.0176 % 110 069 ¥
Nuode Asset Management Co., Ltd.
0.0101 %
18,400 0.0101 % 63 290 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.005615 %
10,200 0.005615 % 35 085 ¥
CCB Principal Asset Management Co., Ltd.
0.000991 %
1,800 0.000991 % 6 191 ¥
CPIC Fund Management Co. Ltd.
0.000127 %
231 0.000127 % 795 ¥

Company contact information

Tianjin Lisheng Pharmaceutical Co., Ltd.

16 Saida North 1st Road Economic & Technology Dev Zone

300385, Tianjin

+86 22 2764 1760

http://www.lishengpharma.com
address Tianjin Lisheng Pharmaceutical Co.,Ltd.(002393)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sector Generic Pharmaceuticals

1st Jan change Capi.
TIANJIN LISHENG PHARMACEUTICAL CO.,LTD. Stock Tianjin Lisheng Pharmaceutical Co.,Ltd.
-5.13% 630M
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.48% 21.89B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.49% 14.45B
CIPLA LIMITED Stock Cipla Limited
+12.69% 13.63B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.37% 11.49B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.76% 6.85B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.35% 5.06B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-5.36% 4.66B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002393 Stock
  4. Company Tianjin Lisheng Pharmaceutical Co.,Ltd.